Bioactivity and secretion of interleukin-18 (IL-18) generated by equine and feline IL-18 expression constructs

Veterinary Immunology and Immunopathology

Volumn 102, Issue 4, 2004, Pages 421-428

  O'Donovan, L H ^a   McMonagle, E L ^a   Taylor, S ^a   Argyle, D J ^a   Nicolson, L ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

Bioassay; Cytokine; IL 18

Indexed keywords

INTERLEUKIN 18; INTERLEUKIN 1BETA; INTERLEUKIN RECEPTOR; PLASMID VECTOR;

ANIMAL CELL; ARTICLE; CAT; CELL SECRETION; CONTROLLED STUDY; CULTURE MEDIUM; DOSE RESPONSE; DRUG ACTIVITY; DRUG ELIMINATION; GENETIC TRANSFECTION; HORSE; HUMAN; HUMAN CELL; NONHUMAN; PROTEIN EXPRESSION; WESTERN BLOTTING;

ANIMALS; BIOLOGICAL ASSAY; CATS; CHO CELLS; CRICETINAE; CRICETULUS; GENE EXPRESSION REGULATION; HORSES; INTERFERON TYPE II; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; INTERLEUKIN-18; RECOMBINANT FUSION PROTEINS; SIALOGLYCOPROTEINS;

CRICETINAE; CRICETULUS GRISEUS; EQUIDAE; FELIDAE;

EID: 8444247860     PISSN: 01652427     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vetimm.2004.08.003     Document Type: Article

References (26)

1. O. Billaut-Mulot, T. Idziorek, E. Ban, L. Kremer, L. Dupre, M. Loyens, G. Riveau, C. Locht, A. Capron, and G.M. Bahr Interleukin-18 modulates immune responses induced by HIV-1 Nef DNA prime/protein boost vaccine Vaccine 19 2001 95 102
2. R. Cao, J. Famebo, M. Kurimoto, and Y. Cao Interleukin-18 acts as an angiogenesis and tumor suppresser J. Fed. Am. Soc. Exp. Biol. 13 2000 2195 2202
3. T. Dao, K. Ohashi, T. Kayano, M. Kurimoto, and H. Okamura Interferon-γ-inducing factor, a novel cytokine, enhances Fas ligand-mediated cytotoxicity of murine T helper 1 cells Cell. Immunol. 173 1996 230 235
4. G. Fantuzzi, and C.A. Dinarello Interleukin-18 and interleukin-1β: two cytokine substrates for ICE (caspase-1) J. Clin. Immunol. 19 1999 1 11
5. H. Goto, T. Osaki, K. Nishino, I. Tachibana, Y. Takeda, T. Yoneda, T. Funakoshi, H. Kimura, S. Hayashi, and H. Tahara Construction and analysis of new vector systems with improved interleukin-18 secretion in a xenogeneic human tumor model J. Immunother. 25 Suppl. 1 2002 S35 S41
6. Y. Gu, K. Kuida, H. Tsutsui, G. Ku, K. Hsiao, M.A. Fleming, N. Hayashi, K. Higashino, H. Okamura, K. Nakanishi, M. Kurimoto, T. Tanimoto, R.A. Flavell, V. Sato, M.W. Harding, D.J. Livingston, and M.S. Su Activation of interferon-γ inducing factor mediated by interleukin-1β converting enzyme Science 275 1997 206 209
7. Hanlon, L., 2000. Feline IL-12 and IL-18: adjuvants in FeLV DNA vaccination studies. Ph.D. thesis. University of Glasgow, Glasgow, UK.
8. L. Hanlon, D. Argyle, D. Bain, L. Nicolson, S. Dunham, M.C. Golder, M. McDonald, C. McGillivray, O. Jarrett, J.C. Neil, and D.E. Onions Feline Leukaemia Virus DNA vaccine efficacy is enhanced by coadministration with interleukin-12 (IL-12) and IL-18 expression vectors J. Virol. 75 2001 8424 8433
9. S. Hara, H. Nagai, H. Miyake, K. Yamanaka, S. Arakawa, M. Ichihashi, S. Kamidono, and I. Hara Secreted type of modified interleukin-18 gene transduced into mouse renal cell carcinoma cells induces systemic tumor immunity J. Urol. 165 2001 2039 2043
10. S.H. Kim, D. Cho, and T.S. Kim Induction of in vivo resistance to Mycobacterium avium infection by intramuscular injection with DNA encoding interleukin-18 Immunology 102 2001 234 241
11. K. Konishi, F. Tanabe, M. Taniguchi, H. Yamauchi, T. Tanimoto, M. Ikeda, K. Orita, and M. Kurimoto A simple and sensitive bioassay for the detection of human interleukin-18/interferon-γ-inducing factor using human myelomonocytic KG-1 cells J. Immunol. Meth. 209 1997 187 191
12. L. Kremer, L. Dupre, I. Wolowczuk, and C. Locht In vivo immunomodulation following intradermal injection with DNA encoding IL-18 J. Immunol. 163 1999 3226 3231
13. B. Liu, D. Novick, S.-H. Kim, and M. Rubinstein Production of a biologically active human interleukin 18 requires its prior synthesis as pro-IL-18 Cytokine 12 2000 1519 1525
14. M.J. Micallef, T. Ohtsuki, K. Kohno, F. Tanabe, S. Ushio, M. Namba, K. Torigoe, M. Fujii, M. Ikeda, S. Fukuda, and M. Kurimoto Interferon-γ- inducing factor enhances T helper 1 cytokine production by stimulated human T cells; synergism with interleukin-12 for interferon-γ production Eur. J. Immunol. 26 1996 1647 1651
15. M.J. Micallef, T. Tanimoto, K. Kohno, M. Ikeda, and M. Kurimoto Interleukin 18 induces the sequential activation of natural killer cells and cytotoxic T lymphocytes to protect syngeneic mice from transplantation with Meth A sarcoma Cancer Res. 57 1997 4557 4563
16. M.J. Micallef, K. Yoshida, S. Kawai, T. Hanaya, K. Kohno, S. Arai, T. Tanimoto, K. Torigoe, M. Fujii, M. Ikeda, and M. Kurimoto In vivo antitumor effects of murine interferon-γ-inducing factor/interleukin-18 in mice bearing syngeneic Meth A malignant ascites Cancer Immunol. Immunother. 43 1997 361 367
17. L. Nicolson, M.N. Penha-Goncalves, J.L. Keanie, N.A. Logan, D.J. Argyle, and D.E. Onions Nucleotide sequence of equine interleukin 12 and 18 cDNAs Immunogenetics 50 1999 94 97
18. H. Okamura, K. Nagata, T. Komatsu, T. Tanimoto, Y. Nukata, F. Tanabe, K. Akita, K. Torigoe, T. Okura, S. Fukuda, and M. Kurimoto A novel costimulatory factor for gamma interferon induction found in the livers of mice causes endotoxic shock Inf. Imm. 63 1995 3966 3972
19. T. Osaki, J.-M. Peron, Q. Cai, H. Okamura, P.D. Robbins, M. Kurimoto, M.T. Lotze, and H. Tahara IFN-γ-inducing factor/IL-18 administration mediates IFN-γ and IL-12-independent antitumor effects J. Immunol. 160 1998 1742 1749
20. T. Osaki, W. Hashimoto, A. Gambotto, H. Okamura, P.D. Robbins, M. Kurimoto, M.T. Lotze, and H. Tahara Potent antitumor effects mediated by local expression of the mature form of the interferon-γ inducing factor, interleukin-18 (IL-18) Gene Ther. 6 1999 808 815
21. K. Oshikawa, F. Shi, A.L. Rakhmilevich, P.M. Sondel, D.M. Mahvi, and N.-S. Yang Synergistic inhibition of tumor growth in a murine mammary adenocarcinoma model by combinational gene therapy using IL-12, pro-IL-18, and IL-1β converting enzyme cDNA Proc. Natl. Acad. Sci. U.S.A. 96 1999 13351 13356
22. D. Robinson, K. Shibuya, A. Mui, F. Zonin, E. Murphy, T. Sana, S.B. Hartley, S. Menon, R. Kastelein, F. Bazan, and A. O'Garra IGIF does not drive Th1 development but synergises with IL-12 for interferon-γ production and activates IRAK and NFκB Immunity 7 1997 571 581
23. H. Tsutsui, K. Nakanishi, K. Matsui, K. Higashino, H. Okamura, Y. Miyazawa, and K. Kaneda IFN-γ-inducing factor up-regulates Fas ligand-mediated cytotoxic activity of murine natural killer cell clones J. Immunol. 157 1996 3967 3973
24. S. Ushio, M. Namba, T. Okura, K. Hattori, Y. Nukada, K. Akita, F. Tanabe, K. Konishi, M. Micallef, M. Fujii, K. Torigoe, T. Tanimoto, S. Fukuda, M. Ikeda, H. Okamura, and M. Kurimoto Cloning of the cDNA for human IFN-g-inducing factor, expression in Escerichia coli, and studies on the biological activities of the protein J. Immunol. 156 1996 4274 4279
25. A.G. Wingren, O. Bjorkdahl, T. Labuda, L. Bjork, U. Andersson, U. Gullberg, G. Hedlund, H.-O. Sjogren, T. Kalland, B. Widegren, and M. Dohlsten Fusion of a signal sequence to the interleukin-1β gene directs the protein from cytoplasmic accumulation to extracellular release Cell Immunol. 169 1996 226 237
26. T. Zhang, K. Kawakami, M. Hossain Qureshi, H. Okamura, M. Kurimoto, and A. Saito Interleukin-12 (IL-12) and IL-18 synergistically induce the fungicidal activity of murine peritoneal exudate cells against Cryptococcus neoformans through production of gamma interferon by natural killer cells Inf. Imm. 65 1997 3594 3599